Spring Creek Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Spring Creek Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-750,000	Closed	-$17.9M	–	745
2021 Q1	$17.9M	Buy	+750,000	New	+$13.9M	0.78%	19

Spring Creek Capital's GNMK Position: Q2 2021 in Review

Spring Creek Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 750,000 shares — an estimated $17.9M sold.

Spring Creek Capital first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $17.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Spring Creek Capital reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Spring Creek Capital sold 750,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $17.9M.
Spring Creek Capital first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Spring Creek Capital's GenMark Diagnostics, Inc position peaked at $17.9M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Spring Creek Capital's 13F filing for Q2 2021, filed 13 Aug 2021.